Human Pathology
Volume 37, Issue 3 , Pages 361-368, March 2006

Contribution of microdissection for the detection of microsatellite instability in colorectal cancer

  • Marie Danjoux

      Affiliations

    • INSERM U563, Centre de Physiopathologie de Toulouse Purpan, CHU Purpan, 31059 Toulouse, France
    • Service d'Anatomie et de Cytologie Pathologiques, CHU Purpan, 31059 Toulouse, France
  • ,
  • Rosine Guimbaud

      Affiliations

    • INSERM U563, Centre de Physiopathologie de Toulouse Purpan, CHU Purpan, 31059 Toulouse, France
    • Département d'oncologie médicale, Centre Claudius Regaud, 20-24, rue du pont St Pierre, 31052 Toulouse, France
  • ,
  • Talal Al Saati

      Affiliations

    • Plate-forme d'histopathologie expérimentale, IFR30, CHU Purpan, 31059 Toulouse, France
  • ,
  • Fabienne Meggetto

      Affiliations

    • INSERM U563, Centre de Physiopathologie de Toulouse Purpan, CHU Purpan, 31059 Toulouse, France
  • ,
  • Nicolas Carrère

      Affiliations

    • Services de chirurgie digestive, CHU Purpan, 31059 Toulouse, France
  • ,
  • Guillaume Portier

      Affiliations

    • Services de chirurgie digestive, CHU Purpan, 31059 Toulouse, France
  • ,
  • Georges Delsol

      Affiliations

    • INSERM U563, Centre de Physiopathologie de Toulouse Purpan, CHU Purpan, 31059 Toulouse, France
  • ,
  • Janick Selves

      Affiliations

    • INSERM U563, Centre de Physiopathologie de Toulouse Purpan, CHU Purpan, 31059 Toulouse, France
    • Service d'Anatomie et de Cytologie Pathologiques, CHU Purpan, 31059 Toulouse, France
    • Corresponding Author InformationCorresponding author. Laboratoire D'Anatomie Pathologique, CHU-Purpan Place du Docteur Baylac, 31059 Toulouse Cedex, France.

Received 1 January 2005; accepted 1 June 2005.

Summary 

The determination of microsatellite instability (MSI) is an important step in the identification of familial colorectal cancer such as hereditary nonpolyposis colon cancer. It could also be of interest in the therapeutic management of sporadic cancer. International criteria for the determination of MSI have been published, recommending the use of microdissection. The aim of this work was to evaluate the impact of contaminant normal DNA in tumor samples for MSI assessment in colorectal cancer using a microdissection technique. We performed a comparative analysis of the microsatellite status between total DNA (DNA extracted from whole tumor samples) and microdissected DNA in 3 different regions from 23 cases of colorectal cancer. Six microsatellites were amplified using fluorescent polymerase chain reaction. We analyzed 9 cases with MSI and 14 cases without instability, with similar results between total DNA and microdissected DNA. Moreover, within a same tumor, the MSI phenotype was observed regardless of the region analyzed. Thus, this work shows the reproducibility of the MSI phenotype throughout a tumor. However, we observed a regional heterogeneity of the MSI profile, consisting of variations in the number and the size of unstable alleles within different regions. This result reflects the genetic heterogeneity of colorectal cancer with MSI. In the 14 cases without instability, we observed an increase of more than 60% in the loss of heterozygosity detection rate after microdissection. Thus, this work confirms the contribution of microdissection for loss of heterozygosity assessment.

Keywords: Colorectal cancer, Microsatellite instability, Genetic heterogeneity, Microdissection, Loss of heterozygosity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was supported by a grant from the “Projet Hospitalier de Recherche Clinique” (no. 00-08) and the “Ligue contre le cancer.” We acknowledge the “Délégation Régionale à la Recherche Clinique des Hopitaux de Toulouse” (AOL no. 98-36L) for its financial support.

PII: S0046-8177(05)00753-7

doi:10.1016/j.humpath.2005.06.022

Human Pathology
Volume 37, Issue 3 , Pages 361-368, March 2006